Difference between revisions of "Pfister S, et al. J. Clin. Oncol. (2009) cited as Ref 116 in DOI: 10.1038/s41392-020-0110-5 (Q9379)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 27, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci (English) | ||
| Property / title: Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:51, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pfister S, et al. J. Clin. Oncol. (2009) cited as Ref 116 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pfister S
0 references
2009
0 references
J. Clin. Oncol.
0 references
27
0 references
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci (English)
0 references
